SK Hynix Targets $29.4 Billion Nasdaq Listing to Expand AI Chip Business 
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Nike CFO Shake-Up Fuels Concerns Over Turnaround Strategy 
Doncasters Raises $919 Million in NYSE IPO as Aerospace Growth Accelerates 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
Alibaba Shares Fall After Anthropic Alleges Massive AI Model Distillation Campaign 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
Samsung and SK Hynix Shares Jump After Micron Earnings Boost AI Chip Optimism 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
Nissan Halts Electric Qashqai Development Amid EV Market Challenges 
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million 
SK Hynix Moves Closer to New York ADR Listing Amid AI Chip Boom 
SAN ANTONIO, Texas, Feb. 23, 2016 -- In a new analysis by Verify Markets, the Asia Pacific healthcare 3D printing market was estimated to be over $35.0 million in 2015. The market is primarily driven by rise in demand for customized prosthetics, as well as the emergence of Asia Pacific as a medical tourism hub. China was the largest market in 2015, making up more than 35 percent of the total market in revenue.
The Asia Pacific healthcare 3D printing market is expected to experience a double-digit growth rate during the forecast period (2016-2022). Increasing competition and government support for smart manufacturing is expected to elevate the Chinese market. Increasing demand for customized prosthetics and higher spending power among patients are expected to drive growth in the Australian healthcare 3D printing market. South Korea, Singapore and Malaysia are emerging as medical tourism destinations. The use of biological material to print human organs in the future will likely revolutionize the industry.
3D printing services are preferred over direct purchase of 3D printers due to the high initial costs associated with upfront printer purchase. The use of 3D printers in various healthcare applications (such as dental, surgery and prototyping, among others) is expected to rise during the forecast period. The Asia Pacific 3D printing market is still emerging and is highly competitive with the presence of both local and international participants.
The key companies in this market include Stratasys, Ltd., Materialise NV, 3D Printing Systems Corporation, Tiertime, Shaanxi Hengtong Intelligent Machine Co., Ltd., Wuhan Binhu Mechanical & Electrical Co., Ltd., Made for ME, Carmina, Rokit, Moment, Imaginarium, J Group Robotics and Brahma3, among others.
The countries covered in this research include China, India, Malaysia, Singapore, Taiwan, South Korea, and Australia. The report is highly detailed and provides key market drivers, restraints, revenue forecasts by technology, service and materials, market share analysis, and key market trends by each country. The base year for the study in 2015 and revenue forecasts are provided until 2022. For additional information, please review our report titled ‘Asia Pacific Healthcare 3D Printing Market’. For more reports on the Healthcare IT market, please visit our website or email us at [email protected]. Follow us for more updates on Twitter @verify_markets and LinkedIn: https://www.linkedin.com/company/verify-markets.
Contact: Haley Rico Phone: 210-595-9687 Email: [email protected]
